18-0040
DL-Lactic acid
JIS special grade, 85.0-92.0%
Synonym(s):
2-Hydroxypropionic acid
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
CH3CH(OH)COOH
CAS Number:
Molecular Weight:
90.08
PubChem Substance ID:
UNSPSC Code:
51113400
Beilstein/REAXYS Number:
1209341
MDL number:
Assay:
85.0-92.0%
Form:
liquid
Grade:
JIS special grade
grade
JIS special grade
assay
85.0-92.0%
form
liquid
availability
available only in Japan
refractive index
n20/D 1.425 (lit.)
pH
2
bp
122 °C/15 mmHg (lit.)
density
1.209 g/mL at 25 °C (lit.)
SMILES string
CC(O)C(O)=O
InChI
1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)
InChI key
JVTAAEKCZFNVCJ-UHFFFAOYSA-N
Still not finding the right product?
Explore all of our products under DL-Lactic acid
signalword
Danger
hcodes
Hazard Classifications
Eye Dam. 1 - Skin Corr. 1C
supp_hazards
Storage Class
8A - Combustible corrosive hazardous materials
wgk
WGK 1
flash_point_f
165.2 °F
flash_point_c
74 °C
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Mohamed Ali Abdel-Rahman et al.
Biotechnology advances, 31(6), 877-902 (2013-04-30)
Fermentative production of optically pure lactic acid has roused interest among researchers in recent years due to its high potential for applications in a wide range of fields. More specifically, the sharp increase in manufacturing of biodegradable polylactic acid (PLA)
Annabelle Olsson et al.
Journal of wildlife diseases, 49(3), 560-567 (2013-06-20)
Using a prospective, randomized study design we demonstrate that midazolam sedation minimizes acidosis compared with physical restraint in captive juvenile estuarine crocodiles during handling or noninvasive procedures at preferred body temperature. A dose of midazolam (5.0 mg/kg) was administered intramuscularly
Stephen Yiu Chuen Choi et al.
The Journal of pathology, 230(4), 350-355 (2013-06-05)
The common preference of cancers for lactic acid-generating metabolic energy pathways has led to proposals that their reprogrammed metabolism confers growth advantages such as decreased susceptibility to hypoxic stress. Recent observations, however, suggest that it generates a novel way for